Skip to main content
SpringerLink
Log in

Tic-Störungen

  • Chapter
  • First Online:
Neuro-/Psychopharmaka im Kindes- und Jugendalter

Zusammenfassung

Bis heute fehlen direkte Vergleiche zwischen pharmakologischer und nichtpharmakologischer Behandlung von Tic-Störungen inklusive Tourette-Syndrom. Eine pharmakologische Behandlung soll dann gewählt werden, wenn subjektive bzw. objektive Belastungen durch die Tics längerfristig ein von den Betroffenen nicht mehr akzeptables Maß an Beeinträchtigung erreichen. Dies können körperliche Schmerzen, Ausgrenzung mit psychosozialem Rückzug, schulische Schwierigkeiten usw. sein. Eine Medikation hat nach heutigem Wissensstand nur eine lindernde, d. h. die Tics reduzierende, aber keine heilende Wirkung. Ziel ist daher eine Reduktion der Tics auf ein erträgliches Maß, kein vollständiges Sistieren. Im folgenden Kapitel sind vor allem die Dopamin-Antagonisten mit guter Wirksamkeit auf Tics aufgeführt. Es werden aber auch Hinweise hinsichtlich der Berücksichtigung von komorbiden Störungen bei der Behandlungsplanung gegeben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF (2006) A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 11:622–632

    Article  CAS  PubMed  Google Scholar 

  • Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF (2009) Meta-analysis: treatment of attention-deficit /hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adeolesc Psychiatry 48:884–893

    Article  Google Scholar 

  • Cath DC, Hedderly T, Ludolph AG, ESSTS Guidelines Group, - (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry 20:155–171

    Article  PubMed  PubMed Central  Google Scholar 

  • Cortese S, Holtmann M, Banaschewski T et al (2013) Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psyc 54:227–246 (on behalf of the European ADHD Guidelines Group)

    Article  Google Scholar 

  • Cummings DD, Singer HS, Krieger M, Miller TL, Mahone EM (2002) Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study. Clin Neuropharmacol 25:325–332

    Article  CAS  PubMed  Google Scholar 

  • Dilling H, Mombour W, Schmidt MH (Hrsg) (2013) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien, 9. Aufl. Huber, Bern

    Google Scholar 

  • Döpfner M, Roessner V, Woitecki K, Rothenberger A (2010) Tic-Störungen. Leitfaden Kinder- und Jugendpsychiatrie Bd. 13. Hogrefe, Göttingen

    Google Scholar 

  • Eggers C, Rothenberger A, Berghaus U (1988) Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 237:223–229

    Article  CAS  PubMed  Google Scholar 

  • Falkai P, Wittchen H-U (Hrsg) (2015) American Psychiatric Association. Diagnostisches und Statistisches Manual Psychischer Störungen DSM-5®. Hogrefe, Göttingen

    Google Scholar 

  • Freeman RD (2007) Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome. Eur Child Adolesc Psychiatry 16(Suppl 1):15–23

    Article  PubMed  Google Scholar 

  • Gevensleben H, Kleemeyer M, Rothenberger LG et al (2013) Neurofeedback in ADHD: further pieces of the puzzle. Brain Topogr 27:20–32

    Article  PubMed  Google Scholar 

  • Ghanizadeh A, Haghighi A (2014) Aripiprazole versus risperidone for treating children and adolescents with tic disorder: A randomized double blind clinical trial. Child Psychiatry Hum Dev 45:596–603

    Article  PubMed  Google Scholar 

  • Ho CS, Chen HJ, Chiu NC, Shen EY, Lue HC (2009) Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder. J Formos Med Assoc 108:788–793

    Article  CAS  PubMed  Google Scholar 

  • Howson AL, Batth S, Ilivitsky V, Boisjoli A, Jaworski M, Mahoney C, Knott VJ (2004) Clinical and attentional effects of acute nicotine treatment in Tourette‘s syndrome. Eur Psychiatry 1:102–112

    Article  Google Scholar 

  • Jankovic J, Kurlan R (2011a) Tourette syndrome evolving concepts. Mov Disord 26:1149–1156

    Article  PubMed  Google Scholar 

  • Jankovic J, Kurlan R (2011b) Reply to: treatment of tics in patients with Tourette Syndrome: recommendations according to the European Society for the Study of Tourette Syndrome. Mov Disord 26:2448

    Article  Google Scholar 

  • Kurlan R (2003) Tourette‘s syndrome: are stimulants safe? Curr Neurol Neurosci Rep 3:285–288

    Article  PubMed  Google Scholar 

  • Kurlan R, Johnson D, Kaplan EL (2008) Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics 121:1188–1197

    Article  PubMed  Google Scholar 

  • Lieberman JA (2004) Dopamine partial agonists. A new class of antipsychotics. CNS Drugs 18:251–267

    Article  CAS  PubMed  Google Scholar 

  • Mogwitz S, Buse J, Ehrlich S, Roessner V (2013) Clinical pharmacology of dopamine-‘modulating agents’ in Tourette’s syndrome. Int Rev Neurobiol 112:281–349

    Article  CAS  PubMed  Google Scholar 

  • Müller-Vahl KR, Schneider U, Prevedel H, Theloe K, Kolbe H, Daldrup T, Emrich HM (2003) Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry 64:459–465

    Article  PubMed  Google Scholar 

  • Müller-Vahl K, Münchau A, Poewe W, Roessner V, Rothenberger A, Vingerhoets F et al (2008) Ticstörungen. In: Diemer HC, Putzki N (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie, 4. Aufl. Thieme, Stuttgart, S 125–129

    Google Scholar 

  • Müller-Vahl KR, Cath DC, Cavanna AE, ESSTS Guidelines Group, - (2011a) European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry 20:209–217

    Article  PubMed  Google Scholar 

  • Müller-Vahl KR, Roessner V (2011b) Treatment of tics in patients with Tourette Syndrome: recommendations according to the European Society for the Study of Tourette Syndrome. Mov Disord 26:2447 (on behalf of the European Society for the Study of Tourette Syndrome (ESSTS))

    Article  PubMed  Google Scholar 

  • Palumbo D, Spencer T, Lynch J, Co-Chien H, Faraone SV (2004) Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy. J Child Adolesc Psychopharmacol 14:185–194

    Article  PubMed  Google Scholar 

  • Robertson MM, Stern JS (2000) Gilles de la Tourette syndrome: symptomatic treatment based on evidence. Eur Child Adolesc Psychiatry 9(Suppl 1):I60–I75

    Article  PubMed  Google Scholar 

  • Roessner V, Rothenberger A (2013) Pharmacological treatment of tics. In: Martino D, Leckman JF (Hrsg) Tourette Syndrome. Oxford Press, New York

    Google Scholar 

  • Roessner V, Banaschewski T, Rothenberger A (2004) Z Kinder Jug-Psych. Therapy of tic disorders 32:245–263

    Google Scholar 

  • Roessner V, Becker A, Banaschewski T, Rothenberger A (2005) Tic disorders and obsessive compulsive disorder: where is the link? In: Brooks DJ, Fleischhacker WW (Hrsg) Neurodevelopmental disorders. Springer, Wien, S 69–99

    Chapter  Google Scholar 

  • Roessner V, Robatzek M, Knapp G, Banaschewski T, Rothenberger A (2006) First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants. Dev Med Child Neurol 48:616–621

    Article  PubMed  Google Scholar 

  • Roessner V, Plessen KJ, Rothenberger A, ESSTS Guidelines Group, - (2011a) European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry 20:173–196

    Article  PubMed  PubMed Central  Google Scholar 

  • Roessner V, Rothenberger A, Rickards H, Hoekstra PJ (2011b) European clinical guidelines for Tourette syndrome and other tic disorders. Eur Child AdolescPsychiatry 20:153–154

    Article  Google Scholar 

  • Rothenberger A (1976) Zur Therapie kindlicher Verhaltensstörungen mit Sulpirid. Kinderarzt 5:561–563

    Google Scholar 

  • Rothenberger A, Banaschewski T, Roessner V (2007) Tic-Störungen. In: DGKJPP, BAG, PKJPP (Hrsg) Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter, 3. Aufl. Deutscher Ärzteverlag, Köln, S 319–325

    Google Scholar 

  • Rothenberger A, Roessner V (2013) The phenomenology of attention-deficit/hyperactivity disorder in Tourette syndrome. In: Martino D, Leckman JF (Hrsg) Tourette-Syndrome. Oxford Press, New York, S 26–49

    Chapter  Google Scholar 

  • Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G (1997) Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette‘s disorder. Am J Psychiatry 154:1057–1062

    Article  CAS  PubMed  Google Scholar 

  • Sallee FR, Kurlan R, Goetz CG et al (2000) Ziprasidone treatment of children and adoelscents with Tourette’s syndrome: a pilot study. J Am Acad Child Psychiatry 39:292–299

    Article  CAS  Google Scholar 

  • Scahill L (2009) Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness. CNS Drugs 23:43–49

    Article  CAS  PubMed  Google Scholar 

  • Scahill L, Riddle MA, King RA, Hardin MT, Rasmusson A, Makuch RW, Leckman JF (1997) Fluoxetine has no marked effect on tic symptoms in patients with Tourette‘s syndrome: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 7:75–85

    Article  CAS  PubMed  Google Scholar 

  • Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS (2003) A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 60:1130–1135

    Article  CAS  PubMed  Google Scholar 

  • Schmider J, Hoff P (1998) Clozapine in Tourette‘s syndrome. J Clin Psychopharmacol 18:88–89

    Article  CAS  PubMed  Google Scholar 

  • Tourette Syndrome Study Group (2002) Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 58:527–536

    Article  Google Scholar 

  • Verdellen C, van de Griendt J, Hartmann A, Murphy T, ESSTS Guidelines Group (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Euro Child Adolesc Psychiatry 20:197–207

    Article  Google Scholar 

  • Weisman H, Qureshi A, Leckman JF, Scahill L, Bloch MH (2013) Systematic review: Pharmacological treatment of tic disorders efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci Biobehav Rev 37:1162–1171

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yoo HK, Joung YS, Lee JS et al (2013) A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette’s disorder. J Clin Psychiatry 74(8):e772–e780

    Article  CAS  PubMed  Google Scholar 

  • Zheng Y, Zhang Z-J, Han X-M et al (2015) A proprietary herbal medicine (5-ling granule) for Tourette syndrome: a randomized controlled trial. J Child Psychol Psychiatry. Doi:10.1111/jcpp.12432

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Kinder- und Jugendpsychiatrie und –psychotherapie, Universitätklinikum Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Deutschland

    Prof. Dr. med. Veit Roessner

  2. Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie, Universitätsmedizin Göttingen, von-Siebold-Straße 5, 37075, Göttingen, Deutschland

    Prof. Dr. med. Aribert Rothenberger

Authors
  1. Prof. Dr. med. Veit Roessner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Aribert Rothenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Veit Roessner .

Editor information

Editors and Affiliations

  1. Zentrum für Seelische Gesundheit, Universitätsklinikum Würzburg, Würzburg, Germany

    Manfred Gerlach

  2. Privatklinik für Seelische Gesundheit, J, HEMERA Klinik, Bad Kissingen, Germany

    Claudia Mehler-Wex

  3. Zentrum für Kinder- und Jugendpsychiatri, Universität Zürich, Zürich, Zürich, Switzerland

    Susanne Walitza

  4. Zentrum für Seelische Gesundheit, Universitätsklinikum Würzburg, Würzburg, Bayern, Germany

    Andreas Warnke

  5. Abteilung Kinder Jugendpsychiatrie, Kliniken der Stadt Köln gGmbH, Köln, Germany

    Christoph Wewetzer

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Roessner, V., Rothenberger, A. (2016). Tic-Störungen. In: Gerlach, M., Mehler-Wex, C., Walitza, S., Warnke, A., Wewetzer, C. (eds) Neuro-/Psychopharmaka im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48624-5_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-48624-5_26

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-48623-8

  • Online ISBN: 978-3-662-48624-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation